Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Dementia01:30

Dementia

660
Dementia is a collective term for cognitive disorders primarily affecting memory, thinking, and reasoning. It is not a specific disease but a syndrome, with Alzheimer's disease being the most common cause, accounting for approximately 60-80% of cases. Other types include vascular dementia, Lewy body dementia, and frontotemporal dementia. Dementia affects millions worldwide, particularly older adults, though it is not a normal part of aging.
The progression of dementia is generally gradual....
660
Alzheimer's Disease: Overview01:26

Alzheimer's Disease: Overview

1.9K
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
1.9K
Alzheimer's Disease: Treatment01:22

Alzheimer's Disease: Treatment

1.1K
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
1.1K
Parkinson's Disease: Overview01:15

Parkinson's Disease: Overview

2.3K
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
2.3K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Case management by Norwegian municipal dementia resource teams - fulfilling the role.

Aging & mental health·2026
Same author

Potentially inappropriate medications related to two-year progression of mild cognitive impairment and dementia.

European journal of clinical pharmacology·2026
Same author

U.S. public perceptions on whether risk of dementia and stroke can be modified through maintaining or changing lifestyle.

BMC public health·2025
Same author

Reply to: Integrating acceptance and commitment therapy in the management of depression in elderly people with epilepsy: A multidimensional perspective and causal analysis.

Epilepsy & behavior : E&B·2025
Same author

Automatic MRI Volumetry Assisted Visual Assessment of the Medial Temporal Lobe in Clinical Dementia Work-Up.

Brain and behavior·2025
Same author

Psychometric evaluation of the Norwegian version of the Threadgold Communication Tool.

International journal of nursing studies advances·2025

Related Experiment Video

Updated: Mar 16, 2026

Abbiategrasso Brain Bank Protocol for Collecting, Processing and Characterizing Aging Brains
12:28

Abbiategrasso Brain Bank Protocol for Collecting, Processing and Characterizing Aging Brains

Published on: June 3, 2020

18.4K

Frontotemporal Dementia: An Updated Clinician's Guide.

Tor Atle Rosness1, Knut Engedal2, Zeina Chemali3

  • 1Lovisenberg Diaconal University College, Oslo, Norway rosness@gmail.com.

Journal of Geriatric Psychiatry and Neurology
|August 10, 2016
PubMed
Summary

Frontotemporal dementia (FTD) is a common early-onset dementia often misdiagnosed due to varied symptoms. Early diagnosis and tailored treatments are crucial for improving quality of life for patients and caregivers.

Keywords:
dementiaearly-onset dementiafrontotemporal dementia

More Related Videos

The 4 Mountains Test: A Short Test of Spatial Memory with High Sensitivity for the Diagnosis of Pre-dementia Alzheimer's Disease
06:23

The 4 Mountains Test: A Short Test of Spatial Memory with High Sensitivity for the Diagnosis of Pre-dementia Alzheimer's Disease

Published on: October 13, 2016

34.1K
Traditional Trail Making Test Modified into Brand-new Assessment Tools: Digital and Walking Trail Making Test
08:07

Traditional Trail Making Test Modified into Brand-new Assessment Tools: Digital and Walking Trail Making Test

Published on: November 23, 2019

12.0K

Related Experiment Videos

Last Updated: Mar 16, 2026

Abbiategrasso Brain Bank Protocol for Collecting, Processing and Characterizing Aging Brains
12:28

Abbiategrasso Brain Bank Protocol for Collecting, Processing and Characterizing Aging Brains

Published on: June 3, 2020

18.4K
The 4 Mountains Test: A Short Test of Spatial Memory with High Sensitivity for the Diagnosis of Pre-dementia Alzheimer's Disease
06:23

The 4 Mountains Test: A Short Test of Spatial Memory with High Sensitivity for the Diagnosis of Pre-dementia Alzheimer's Disease

Published on: October 13, 2016

34.1K
Traditional Trail Making Test Modified into Brand-new Assessment Tools: Digital and Walking Trail Making Test
08:07

Traditional Trail Making Test Modified into Brand-new Assessment Tools: Digital and Walking Trail Making Test

Published on: November 23, 2019

12.0K

Area of Science:

  • Neurology
  • Geriatrics
  • Genetics

Background:

  • Frontotemporal dementia (FTD) is a leading cause of dementia before age 65.
  • FTD diagnosis is challenging due to symptom overlap with psychiatric and neurological disorders.
  • Genetic factors are known risks, but lifestyle, comorbidity, and environmental influences remain unclear.

Purpose of the Study:

  • To highlight the diagnostic challenges of frontotemporal dementia (FTD).
  • To discuss the known and unknown risk factors for FTD.
  • To emphasize the importance of early diagnosis and tailored treatment for FTD.

Main Methods:

  • Review of current literature on frontotemporal dementia (FTD).
  • Analysis of diagnostic criteria and challenges.
  • Examination of genetic, lifestyle, and environmental risk factors.

Main Results:

  • FTD symptoms often mimic other conditions, delaying diagnosis.
  • While genetics play a role, environmental and lifestyle factors require further investigation.
  • Lack of insight is a common early indicator of FTD.

Conclusions:

  • Early detection and intervention in FTD are vital.
  • Personalized treatment strategies can significantly improve patient and caregiver outcomes.
  • Further research is needed to elucidate non-genetic risk factors for FTD.